Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Virtual Booth

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Azd-1656, Azd1656, 919783-22-5, Azd 1656, 660m185x4d, 3-((5-(azetidin-1-ylcarbonyl)pyrazin-2-yl)oxy)-5-((1s)-2-methoxy-1-methylethoxy)-n-(5-methylpyrazin-2-yl)benzamide

Molecular Formula

C₂₄H₂₆N₆O₅

Molecular Weight

478.5 g/mol

InChI Key

FJEJHJINOKKDCW-INIZCTEOSA-N

FDA UNII

660M185X4D

AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes).

1 2D Structure

AZD1656

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(2S)-1-methoxypropan-2-yl]oxy-N-(5-methylpyrazin-2-yl)benzamide

2.1.2 InChI

InChI=1S/C24H26N6O5/c1-15-10-27-21(12-25-15)29-23(31)17-7-18(34-16(2)14-33-3)9-19(8-17)35-22-13-26-20(11-28-22)24(32)30-5-4-6-30/h7-13,16H,4-6,14H2,1-3H3,(H,27,29,31)/t16-/m0/s1

2.1.3 InChI Key

FJEJHJINOKKDCW-INIZCTEOSA-N

2.1.4 Canonical SMILES

CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)OC(C)COC)OC3=NC=C(N=C3)C(=O)N4CCC4

2.1.5 Isomeric SMILES

CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)O[C@@H](C)COC)OC3=NC=C(N=C3)C(=O)N4CCC4

2.2 Other Identifiers

2.2.1 UNII

660M185X4D

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Azd1656

2.3.2 Depositor-Supplied Synonyms

1. Azd-1656

2. Azd1656

3. 919783-22-5

4. Azd 1656

5. 660m185x4d

6. 3-((5-(azetidin-1-ylcarbonyl)pyrazin-2-yl)oxy)-5-((1s)-2-methoxy-1-methylethoxy)-n-(5-methylpyrazin-2-yl)benzamide

7. 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(1s)-2-methoxy-1-methylethoxy]-n-(5-methylpyrazin-2-yl)benzamide

8. Schembl321593

9. Gtpl7701

10. Chembl3219124

11. Unii-660m185x4d

12. Azd 1656 [who-dd]

13. At32772

14. Db14810

15. Ba171838

16. Cid 16039797

17. Hy-15675

18. Cs-0008226

19. E77313

20. Q27074714

21. (s)-3-(5-(azetidine-1-carbonyl)pyrazin-2-yloxy)-5-(1-methoxypropan-2-yloxy)-n-(5-methylpyrazin-2-yl)benzamide

22. Benzamide, 3-((5-(1-azetidinylcarbonyl)-2-pyrazinyl)oxy)-5-((1s)-2-methoxy-1-methylethoxy)-n-(5-methyl-2-pyrazinyl)-

2.4 Create Date

2007-04-16

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₆N₆O₅
Molecular Weight	478.5 g/mol
XLogP3	1.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	9
Exact Mass	478.19646795 g/mol
Monoisotopic Mass	478.19646795 g/mol
Topological Polar Surface Area	129 Å²
Heavy Atom Count	35
Formal Charge	0
Complexity	710
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1